Skip to content
OpenCapital
Get started

FactSet Research Systems FDS Number of shares purchased (in shares)

Number of shares purchased (in shares) at other companies

Northern Trust logo
Northern TrustNTRS
——

Other financials

Income statement

See full
Revenue$611.0M+7.1%
Gross profit$314.3M+4.4%
Operating income$185.0M-0.3%
Net income$133.1M-8.1%
EPS (diluted)$3.59-4.5%

Balance sheet

See full
Cash & equivalents$277.4M-4.9%
Total debt$2.1B+23.5%
Total equity$2.1B+3.5%
Total assets$4.2B-0.5%

Cash flow

See full
Operating cash flow$211.7M+21.7%
CapEx$26.0M+9.5%
Free cash flow$185.7M+23.6%

Valuation

See full
Market cap$8.06B-54.2%
Enterprise value$9.84B-48.1%
P/E13.7×-18.7×
P/S3.4×-4.5×

Profitability

See full
Gross margin51.9%-2.2pp
Operating margin31.2%-0.2pp
Net margin24.5%+0.4pp
FCF margin28.4%+3.4pp

Returns & leverage

See full
Return on equity28.1%0.0pp
Debt / equity1×+0.2×
Current ratio1.4×0.0×

Where this comes from

Reported directly by FactSet Research Systems in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockSharesAcquired.

The official record: FactSet Research Systems’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about FactSet Research Systems's number of shares purchased (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is FactSet Research Systems's number of shares purchased (in shares)?
FactSet Research Systems (FDS) reported number of shares purchased (in shares) of 651.8K in Q4 2025.
How has FactSet Research Systems's number of shares purchased (in shares) changed year-over-year?
FactSet Research Systems's number of shares purchased (in shares) increased by 376.7% year-over-year, from 136.7K to 651.8K.
What does number of shares purchased (in shares) mean?
The total number of common shares repurchased by the company from the open market or other sources during the reporting period. This reflects the company's capital allocation strategy to return value to shareholders or offset dilution from equity compensation.